1. D.W. Foster, Diabetes mellitus, in: A.S. Fauci, E. Braunwald, K.J. Isselbacher et al. (Eds.), Harrison's Principles of Internal Medicine, 14th ed, McGraw-Hill, New York, 1998, pp. 2060–2080.
2. C.R. Kahn, Y. Shechter, Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas, in: A.G. Gilman, T.W. Rall, A.S. Nies, P. Taylor (Eds.), The Pharmacological Basis of Therapeutics, 8th ed., Pergamon Press, New York, 1991, pp. 1463-1495.
3. DCCT: The Diabetes Control and Complications Trial Research Group, The effect of intensive treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus, New Engl. J. Med. 329 (1993) 977–986.
4. Structural requirements for intestinal absorption of peptide drugs;Pauletti;J. Control. Release,1996
5. Studies on the passage of alpha-chymotrypsin across the intestine;Moriya;Chem. Pharm. Bull.,1967